Hypertension and progression of nephropathy in diabetic and non-diabetic chronic kindney disease patients

Hippokratia

Volumn 11, Issue 2, 2007, Pages 72-76

  Stojceva Taneva, O ^a   Selim, G ^a   Stojkovski, L ^a   Ivanovski, N ^a  

^a University Clinical Center Skopje   (Macedonia)

Author keywords

Age; Chronic kidney disease progression; Hypertension; Proteinuria

Indexed keywords

ADULT; AGE DISTRIBUTION; ANALYTICAL PARAMETERS; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEPHROLOGIST; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEINURIA; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

EID: 34249950529     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141:95-101
2. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43 (5 suppl 1): S1-S290
3. Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-Up Program Cooperative Group. Hypertension 1989; 13 (suppl 5):I80-I93
4. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. J Am Med Assoc 1992; 268:3085-3091
5. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123:754-762
6. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. J Am Med Assoc 2002; 288:2421-2431
7. Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139:244-252
8. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252
9. Mulrow PJ. Detection and control of hypertension in the population: the United States experience. Am J Hypertens 1998; 11:744-746
10. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339:1957-1963
11. Julius S. Worldwide trends and shortcomings in the treatment of hypertension. Am J Hypertens 2000; 13 (suppl):S57-S61
12. Chaudhry SI, Krumholz HM, Foody JM. Systolic hypertension in older persons. J Am Med Assoc 2004; 292:1074-1080
13. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594-599
14. Bielak LF, Turner ST, Franklin SS, Sheedy PF II, Peyser PA. Age-dependent associations between blood pressure and coronary artery calcification in asymptomatic adults. J Hypertens 2004; 22:719-725
15. Haider AW, Larson MG, Franklin SS, Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10-16
16. De Nicola L, Minutolo R, Gallo C, et al. Management of hypertension in chronic kidney disease: The Italian multicentric study. JN 2005; 18:397-404
17. Triolo L, Cattaruzza MS, Sicoli R, et al. Blood pressure control and comorbidity in a nephrology clinic. JN 2004; 17:808-812
18. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 1998; 53:1209-1216
19. Sarnak MJ, Greene T, Wang X, et al. Ann Intern Med 2005; 142:342-351
20. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004; 66:1596-605
21. Leehey DJ, Kramer HJ, Daoud TM, Chatha MP, Isreb MA. Progression of kidney disease in type 2 diabetes - beyond blood pressure control: an observational study. BMC Nephrology 2005; 6:8